ATTRALUS

Welcome to the Brand page for “ATTRALUS”, which is offered here for Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, light chain amyloidosis and lect2 amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use;.

Its status is currently believed to be active. Its class is unavailable. “ATTRALUS” is believed to be currently owned by “ATTRALUS, INC.”